Stay updated on Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Sign up to get notified when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    An update to the page's revision tag from v3.5.4 to v3.5.5 was applied, indicating a backend/content-management update. This signals a page refresh or republishing rather than changes to the study data or listings.
    Difference
    0.1%
    Check dated 2026-06-05T21:32:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Publications section updated: the older JCO reference with an Erratum is removed, and a newer JCO publication citation related to HER2-mutant cancers is added. This reflects an updated bibliographic record for results associated with the study.
    Difference
    0.1%
    Check dated 2026-05-15T11:41:40.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, reflecting an incremental site/version change without altering the displayed clinical trial study content.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:21.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added an erratum note for the JCO 2018 publication. Updated the publication revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:30.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:09:04.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.4.2 to v3.4.3. No trial content or visible details appear to be altered.
    Difference
    0.1%
    Check dated 2026-03-12T02:22:18.000Z thumbnail image

Stay in the know with updates to Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.